Expression Table for this CRE
| CNhs14417 | 293SLAM rinderpest infection, 24hr, biol_rep2 | 14.0 |
| CNhs14078 | amygdala, newborn, donor10223 | 12.5 |
| CNhs14082 | globus pallidus, newborn, donor10223 | 4.6 |
| CNhs13099 | serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1 | 3.4 |
| SRX6586336 | CNhi10317_MCF-7_Rosuvastatin-30 uM-6h_rep1 | 3.2 |
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 3.1 |
| CNhs13843 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 2.6 |
| SRX6586357 | CNhi10330_MCF-7_siRNA-negative control-48h_rep5 | 2.4 |
| CNhs13831 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 2.4 |
| CNhs12080 | Meningeal Cells, donor2 | 2.2 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 2.2 |
| CNhs13840 | iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 2.1 |
| CNhs13835 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 1.8 |
| SRX6586361 | CNhi10331_MCF-7_siRNA (HSS179267) treatment-48h_rep1 | 1.8 |
| SRX6586343 | CNhi10318_MCF-7_Simvastatin-30 uM-48h_rep1 | 1.7 |
| CNhs13841 | iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 1.6 |
| SRX6586339 | CNhi10318_MCF-7_Atrovastatin-30 uM-48h_rep1 | 1.6 |
| SRX6586337 | CNhi10317_MCF-7_Rosuvastatin-30 uM-6h_rep2 | 1.5 |
| SRX6586342 | CNhi10318_MCF-7_Non-treatment (DMSO)-48h_rep6 | 1.3 |
| SRX6586360 | CNhi10331_MCF-7_siRNA (HSS104864) treatment-48h_rep3 | 1.2 |
| CNhs13060 | acute myeloid leukemia (FAB M6) cell line:F-36E | 1.0 |
| SRX6586352 | CNhi10330_MCF-7_siRNA (HSS104864) treatment-48h_rep1 | 0.9 |
| SRX6586353 | CNhi10330_MCF-7_siRNA-negative control-48h_rep1 | 0.9 |
| CNhs12698 | K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 0.9 |
| SRX6586340 | CNhi10318_MCF-7_Atrovastatin-30 uM-48h_rep2 | 0.9 |
| CNhs13104 | Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6) | 0.9 |
| CNhs13364 | Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20) | 0.9 |
| CNhs14445 | COBL-a rinderpest(-C) infection, 48hr, biol_rep2 | 0.8 |
| SRX6586347 | CNhi10319_MCF-7_Fluvastatin-30 uM-48h_rep2 | 0.8 |
| CNhs12560 | mature adipocyte, donor3 | 0.8 |
| CNhs13379 | Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2) | 0.8 |
| SRX6586338 | CNhi10317_MCF-7_Rosuvastatin-30 uM-6h_rep3 | 0.8 |
| CNhs12807 | plasma cell leukemia cell line:ARH-77 | 0.8 |
| SRX6586359 | CNhi10331_MCF-7_siRNA (HSS104864) treatment-48h_rep2 | 0.8 |
| SRX9760367 | skeletal muscle_1_h_after_exercise (Individual 4) | 0.8 |
| CNhs12741 | Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13) | 0.7 |
| SRX6586351 | CNhi10319_MCF-7_Rosuvastatin-30 uM-48h_rep3 | 0.7 |
| CNhs14473 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2 | 0.7 |
| SRX6586362 | CNhi10331_MCF-7_siRNA (HSS179267) treatment-48h_rep2 | 0.7 |
| CNhs11776 | skeletal muscle, fetal, donor1 | 0.7 |
| SRX6586358 | CNhi10330_MCF-7_siRNA-negative control-48h_rep6 | 0.7 |
| CNhs12054 | Bronchial Epithelial Cell, donor4 | 0.7 |
| CNhs13170 | Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13) | 0.6 |
| CNhs13069 | mesothelioma cell line:Mero-82 | 0.6 |
| CNhs12816 | Melanocyte, donor1 (MC+1) | 0.6 |
| SRX6586346 | CNhi10319_MCF-7_Fluvastatin-30 uM-48h_rep1 | 0.6 |
| SRX6586349 | CNhi10319_MCF-7_Rosuvastatin-30 uM-48h_rep1 | 0.5 |
| CNhs14245 | lung adenocarcinoma, papillary cell line:NCI-H441 | 0.5 |
| CNhs12826 | H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1) | 0.5 |
| CNhs11985 | Smooth Muscle Cells - Brachiocephalic, donor2 | 0.5 |